Hyperleptinaemia and chronic inflammation after peritonitis predicts poor nutritional status and mortality in patients on peritoneal dialysis

Nephrology Dialysis Transplantation

Volumn 22, Issue 5, 2007, Pages 1445-1450

  Lam, Man Fai ^a   Leung, Joseph C K ^a   Lo, Wai Kei ^a   Tam, Sidney ^a   Chong, Mei Ching ^a   Lui, Sing Leung ^a   Tse, Kai Chung ^a   Chan, Tak Mao ^a   Lai, Kar Neng ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hyperleptinaemia; Inflammation; Malnutrition; Peritonitis

Indexed keywords

ADIPONECTIN; ALBUMIN; BICARBONATE; C REACTIVE PROTEIN; CEFAZOLIN; CHOLESTEROL; INTERLEUKIN 6; LEPTIN; PREALBUMIN; TOBRAMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; HYPERLEPTINEMIA; LEAN BODY WEIGHT; MALE; MALNUTRITION; MORTALITY; NUTRITIONAL STATUS; PERITONITIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REMISSION; SURVIVAL RATE;

ADIPONECTIN; AGED; C-REACTIVE PROTEIN; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; LEPTIN; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN-ENERGY MALNUTRITION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34447548972     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl788     Document Type: Article

References (20)

1. Sanchez PL, Palacios IF, Pabon P et al. Relationship between C-reactive protein and the electrocardiographic pattern on admission in patients with acute coronary syndrome. Cardiology 2005; 104: 45-50
2. Wanner C, Zimmermann J, Schwedler S, Metzger T. Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl 2002; 80: 99-102
3. Yeh ET. CRP as a mediator of disease. Circulation 2004; 109 [21 Suppl 1]: II 11-14
4. Zoccali C, Mallamaci F, Tripepi G et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134-141
5. Kalantar-Zade K, Stenvinkel P, Pillon L, Koppel JD. Inflammation and Nutrition in Renal Insufficiency. Adv Ren Replace Ther 2003; 10: 155-169
6. Stenvinkel P, Lindholm B, Lonnqvist F, Katzarski K. Heimburger O. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 2000; 11: 1303-1309
7. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000; 58: 1758-1764
8. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000; 35: 644-652
9. Ducloux D, Bresson-Vautrin C, Kribs M, Abdelfatah A, Chalopin JM. C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Kidney Int 2002; 62: 1417-1422
10. Nascimento MM, Pecoits-Filho R, Lindholm B, Riella MC, Stenvinkel P. Inflammation, malnutrition and atherosclerosis in end-stage renal disease: A global perspective. Blood Purif 2002; 20: 454-458
11. Pecoits-Filho R, Stenvinkel P, Wang AY, Heimburger O, Lindholm B. Chronic inflammation in peritoneal dialysis: The search for the holy grail? Perit Dial Int 2004; 24: 327-339
12. Pasceri V, Cheng JS, Willerson JT, Yeh ET. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001; 103: 2531-2534
13. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000; 15: 953-960
14. Sarraf P, Frederich RC, Turner EM et al. Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia. J Exp Med 1997; 185: 171-175
15. Cheung W, Yu PX, Little BM, Cone RD, Marks DL, Mak RH. Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest 2005; 115: 1659-1665
16. Kolaczynski JW, Nyce MR, Considine RV et al. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes 1996; 45: 699-701
17. Nordfors L, Lonnqvist F, Heimburger O. Danielsson A, Schalling M, Stenvinkel P. Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int 1998; 54: 1267-1275
18. Moshyedi AK, Josephs MD, Abdalla EK et al. Increased leptin expression in mice with bacterial peritonitis is partially regulated by tumor necrosis factor alpha. Infect Immun 1998; 66: 1800-1802
19. Agnello D, Meazza C, Rowan CG, Villa P, Ghezzi P, Senaldi G. Leptin causes body weight loss in the absence of in vivo activities typical of cytokines of the IL-6 family. Am J Physiol 1998; 275: R913-R919
20. Wannamethee SG, Tchernova J, Whincup P et al. Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 2006. [Epub ahead of print]